Vmbook Online ordering
Icons
Sure, I can provide some general information about the company ICON plc, which is a public company listed on the NASDAQ stock exchange in the USA with the stock symbol "ICLR".
ICON plc is a global provider of drug development and commercialization solutions and services to the pharmaceutical, biotechnology, and medical device industries. The company offers a range of services, including clinical trial design and management, data analytics, and strategic consulting.
As of the latest earnings report (Q4 2021), ICON plc reported revenue of $2.35 billion for the full year, representing an increase of 15.5% compared to the previous year. The company's net income for the year was $225.3 million, or $3.53 per share, compared to $195.3 million, or $3.03 per share, in the previous year.
ICON plc has a strong track record of growth, with revenue and earnings increasing consistently over the past several years. The company's earnings per share (EPS) have grown at a compound annual growth rate (CAGR) of 18.2% over the past five years, and its revenue has grown at a CAGR of 11.4% over the same period.
Looking forward, analysts expect ICON plc to continue its strong growth trajectory, with revenue expected to grow at a CAGR of 10.5% over the next five years, and EPS expected to grow at a CAGR of 15.5% over the same period.
In summary, ICON plc is a leading provider of drug development and commercialization solutions, with a strong track record of growth and a positive outlook for the future. The company is well-positioned to benefit from the ongoing demand for its services as the pharmaceutical and biotechnology industries continue to innovate and develop new therapies.